Product NDC: | 44567-716 |
Proprietary Name: | Cefazolin |
Non Proprietary Name: | Cefazolin |
Active Ingredient(s): | 500 mg/1 & nbsp; Cefazolin |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 44567-716 |
Labeler Name: | WG Critical Care, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA063214 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120418 |
Package NDC: | 44567-716-10 |
Package Description: | 10 BOTTLE in 1 CARTON (44567-716-10) > 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
NDC Code | 44567-716-10 |
Proprietary Name | Cefazolin |
Package Description | 10 BOTTLE in 1 CARTON (44567-716-10) > 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
Product NDC | 44567-716 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cefazolin |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120418 |
Marketing Category Name | ANDA |
Labeler Name | WG Critical Care, LLC |
Substance Name | CEFAZOLIN SODIUM |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |